Artwork

Content provided by Integrated Diabetes Services. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Integrated Diabetes Services or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

The Quest for a Cure: A Diamyd In the Rough

38:34
 
Share
 

Manage episode 478407248 series 3575647
Content provided by Integrated Diabetes Services. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Integrated Diabetes Services or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Episode Summary

In Episode 31 of Think Like a Pancreas-The Podcast, host Gary Scheiner and guest Ginger Vieira discuss the innovative approaches being taken by Diamyd Medical in the quest for a cure for type 1 diabetes.

They explore the significance of using precision medicine, and the role of GAD65 therapy to modulate the immune response in the early stages of type one diabetes.

Gary and Ginger share the potential of benefits of Diamyd Medical’s Diagnode-3’s clinical trial, the screening process for participants, and the hope it brings to newly diagnosed individuals.

Key Topics Discussed
  • Recent Vertex results
  • The autoimmune process
  • The importance of precision medicine in treating type 1 diabetes.
  • How GAD65 therapy targets specific antibodies without widespread immune suppression.
  • The process and benefits of participating in clinical trials
  • What is different about Diamyd's Diagnode-3 trial.
  • Who qualifies for the Diagnode-3 trial?
  • What is involved in being a part of Diamyd's clinical trial?
  • How are outcomes measured?

  • What is in it for participants?

Chapters
  • 00:14 – Welcome and Disclaimer
  • 01:00 - Introducing Ginger Vieira
  • 03:09 – Why Ginger is talking about Diamyd
  • 04:00 – Lessons to be learned from Veretex
  • 06:11 - How do you define a cure for type 1 diabetes?
  • 07:33- What is unique about Diamyd's therapy?
  • 08:45 - What is unique about Diamyd's therapy?
  • 11:27 – The importance of pre-diabetes screening
  • 17:19 - The problem of widespread immunosuppression
  • 20:45 - Why should you participate in the Diagnode-3 Clinical Trial?
  • 25:36 - How does Diamyd's clinical trial differ from other trials?
  • 26:56 - Final Thoughts and Future Directions
  • 31:41 - Gary's thoughts on Diamyd Medical's clinical trial

Links:

diabetesnerd.com

https://diagnode-3.com/

Diabetes Research Institute

TrialNet

  continue reading

31 episodes

Artwork
iconShare
 
Manage episode 478407248 series 3575647
Content provided by Integrated Diabetes Services. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Integrated Diabetes Services or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Episode Summary

In Episode 31 of Think Like a Pancreas-The Podcast, host Gary Scheiner and guest Ginger Vieira discuss the innovative approaches being taken by Diamyd Medical in the quest for a cure for type 1 diabetes.

They explore the significance of using precision medicine, and the role of GAD65 therapy to modulate the immune response in the early stages of type one diabetes.

Gary and Ginger share the potential of benefits of Diamyd Medical’s Diagnode-3’s clinical trial, the screening process for participants, and the hope it brings to newly diagnosed individuals.

Key Topics Discussed
  • Recent Vertex results
  • The autoimmune process
  • The importance of precision medicine in treating type 1 diabetes.
  • How GAD65 therapy targets specific antibodies without widespread immune suppression.
  • The process and benefits of participating in clinical trials
  • What is different about Diamyd's Diagnode-3 trial.
  • Who qualifies for the Diagnode-3 trial?
  • What is involved in being a part of Diamyd's clinical trial?
  • How are outcomes measured?

  • What is in it for participants?

Chapters
  • 00:14 – Welcome and Disclaimer
  • 01:00 - Introducing Ginger Vieira
  • 03:09 – Why Ginger is talking about Diamyd
  • 04:00 – Lessons to be learned from Veretex
  • 06:11 - How do you define a cure for type 1 diabetes?
  • 07:33- What is unique about Diamyd's therapy?
  • 08:45 - What is unique about Diamyd's therapy?
  • 11:27 – The importance of pre-diabetes screening
  • 17:19 - The problem of widespread immunosuppression
  • 20:45 - Why should you participate in the Diagnode-3 Clinical Trial?
  • 25:36 - How does Diamyd's clinical trial differ from other trials?
  • 26:56 - Final Thoughts and Future Directions
  • 31:41 - Gary's thoughts on Diamyd Medical's clinical trial

Links:

diabetesnerd.com

https://diagnode-3.com/

Diabetes Research Institute

TrialNet

  continue reading

31 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play